{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:13:39Z","timestamp":1785827619287,"version":"3.56.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00345","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T04:36:34Z","timestamp":1583210194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule"],"prefix":"10.3389","volume":"11","author":[{"given":"Danielle A. M.","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana R.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieda M.","family":"Longo-Maug\u00e9ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara L.","family":"Barbi\u00e9ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"B1","year":"","journal-title":"Leishmaniasis Fact Sheet Updated April 2017."},{"key":"B2","first-page":"p. 242","article-title":"New world leishmaniasis \u2013 the neotropical Leishmania species.","author":"Lainson","year":"1998","journal-title":"Topley & Wilson\u2019s Microbiology and Microbial Infections. Parasitology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.","volume":"114","author":"Nagle","year":"2014","journal-title":"Chem Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.","volume":"8","author":"Goto","year":"2010","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis \u2013 current chemotherapy and recent advances in the search for novel drugs.","volume":"9","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for New World cutaneous leishmaniasis.","volume":"38","author":"Soto","year":"2004","journal-title":"Clin Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis.","volume":"347","author":"Sundar","year":"2002","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/187152007781668661","article-title":"Recent advances involving palladium (II) complexes for cancer therapy.","volume":"7","author":"Caires","year":"2007","journal-title":"Anticancer Agents Me Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1590\/S0103-50532008000700018","article-title":"Palladium polypyridyl complexes: synthesis, characterization, DNA interaction and biological activity on Leishmania (L.) mexicana.","volume":"19","author":"Navarro","year":"2008","journal-title":"J Braz Chem Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1128\/AAC.00323-10","article-title":"In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas\u2019 disease.","volume":"54","author":"Matsuo","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.5935\/0103-5053.20150360","article-title":"Antiprotozoal activity of the cyclopalladated complexes against Leishmania amazonensis and Trypanosoma cruzi.","volume":"27","author":"Vel\u00e1squez","year":"2016","journal-title":"J Braz Chem Soc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1128\/AAC.00137-11","article-title":"CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis.","volume":"55","author":"Gupta","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1128\/AAC.00273-15","article-title":"Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidate.","volume":"59","author":"Seifert","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001626","article-title":"In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.","volume":"6","author":"Paladi","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01427","article-title":"Leishmanicidal and immunomodulatory activities of the palladacycle complex DPPE 1.1, a potential candidate for treatment of cutaneous leishmaniasis.","volume":"9","author":"Santos","year":"2018","journal-title":"Front Microbiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00333","article-title":"Treatment of Leishmania (Leishmania) amazonensis-infected mice with a combination of a palladacycle complex and heat-killed Propionibacterium acnes triggers protective cellular immune responses.","volume":"8","author":"Paladi","year":"2017","journal-title":"Front Microbiol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.159.1.97","article-title":"Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.","volume":"159","author":"Matsui","year":"1997","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0165-2478(03)00079-8","article-title":"Treatment with Propionibacterium acnes modulates the late phase reaction of immediate hypersensitivity in mice.","volume":"88","author":"Braga","year":"2003","journal-title":"Immunol Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.imlet.2008.10.005","article-title":"Modulation of the type I hypersensitivity late phase reaction to OVA by Propionibacterium acnes-soluble polysaccharide.","volume":"121","author":"Squaiella","year":"2008","journal-title":"Immunol Lett."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/132083","article-title":"Modulation of Th1\/Th2 immune responses by killed Propionibacterium acnes and its soluble polysaccharide fraction in a type I hypersensitivity murine model: induction of different activation status of antigen-presenting cells.","volume":"2015","author":"Squaiella","year":"2015","journal-title":"J Immunol Res."},{"key":"B21","author":"Silva","year":"2016","journal-title":"Efeito do Tratamento Com o Complexo Paladaciclo DPPE 1.2 Associado \u00e0 Ciste\u00edna Proteinase Recombinante rLdccys1 Sobre a Infec\u00e7\u00e3o por Leishmania (Leishmania) Amazonensis em Modelo Murino."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1128\/IAI.73.6.3787-3789.2005","article-title":"Recombinant cysteine proteinase from Leishmania (L.) chagasi implicated in human and dog T cell responses.","volume":"73","author":"Pinheiro","year":"2005","journal-title":"Inf Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.vaccine.2007.11.044","article-title":"Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.","volume":"26","author":"Ferreira","year":"2008","journal-title":"Vaccine."},{"key":"B24","author":"Pinheiro","year":"2009","journal-title":"A Ciste\u00edna Proteinase Recombinante de Leishmania (Leishmania) Chagasi (rLdccys1): Alvo Para Diagn\u00f3stico e Imuniza\u00e7\u00e3o Protetora de C\u00e3es de \u00c1rea End\u00eamica de Leishmaniose Visceral, Teresina\/PI."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002729","article-title":"Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the immunotherapy of canine visceral leishmaniasis.","volume":"8","author":"Ferreira","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0014-4894(90)90024-7","article-title":"Lysosomal depletion in macrophages from spleen and foot lesions of Leishmania-infected hamster.","volume":"71","author":"Barbi\u00e9ri","year":"1990","journal-title":"Exp Parasitol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/ijc.11434","article-title":"Cyclopalladated compounds as chemotherapeutic agents: antitumor activity against a murine melanoma cell line.","volume":"107","author":"Rodrigues","year":"2003","journal-title":"Int J Cancer."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033955","article-title":"Adjuvant effect of killed Propionibacterium acnes on mouse peritoneal B-1 lymphocytes and their early phagocyte differentiation.","volume":"7","author":"Mussalem","year":"2012","journal-title":"PLoS One."},{"key":"B29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999","article-title":"A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"7","author":"Bradford","year":"1976","journal-title":"Anal Biochemm."},{"key":"B30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4269\/ajtmh.2005.72.126","article-title":"A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi suitable for serodiagnosis of American visceral leishmaniasis.","volume":"72","author":"Dias","year":"2005","journal-title":"Am J Trop Med Hyg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/prep.1998.1003","article-title":"Overcoming expression and purification problems of RhoGDI using a family of \u201cparallel\u201d expression vectors.","volume":"15","author":"Sheffield","year":"1999","journal-title":"Prot Expres Purif."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/s0264-410x(02)00302-x","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant.","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice.","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/s0020-7519(00)00037-0","article-title":"Identification of a 30kDa antigen from Leishmania (L.) chagasi amastigotes implicated in protective cellular responses in a murine model.","volume":"30","author":"Pinto","year":"2000","journal-title":"Int J Parasitol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1348-0421.2006.tb03791.x","article-title":"Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene.","volume":"50","author":"Mussalem","year":"2006","journal-title":"Microbiol Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.imbio.2005.10.013","article-title":"In vivo and in vitro effect of killed Propionibacterium acnes and its purified soluble polysaccharide on mouse bone marrow stem cells and dendritic cell differentiation.","volume":"211","author":"Squaiella","year":"2006","journal-title":"Immunobiology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1128\/iai.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1128\/IAI.72.8.4521-4527.2004","article-title":"Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.","volume":"72","author":"Pinto","year":"2004","journal-title":"Infect Immun."},{"key":"B39","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/IAI.61.7.2952-2959.1993","article-title":"Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis.","volume":"61","author":"Afonso","year":"1993","journal-title":"Infect Immun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4269\/ajtmh.2002.66.338","article-title":"Analysis of T helper cell responses during infection with Leishmania amazonensis.","volume":"66","author":"Ji","year":"2002","journal-title":"Am J Trop Med Hyg."},{"key":"B41","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/IAI.63.9.3559-3566.1995","article-title":"Leishmania pifanoi amastigote antigens protect mice against leishmaniasis.","volume":"63","author":"Soong","year":"1995","journal-title":"Infect Immun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0001-706x(95)00120-4","article-title":"In vivo protective effect of the lectin from Canavalia brasiliensis on BALB\/c mice infected by Leishmania amazonensis.","volume":"60","author":"Barral-Neto","year":"1996","journal-title":"Acta Tropica."},{"key":"B43","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4049\/jimmunol.165.1.364","article-title":"IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.","volume":"165","author":"Jones","year":"2000","journal-title":"J Immun."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013815","article-title":"Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages.","volume":"5","author":"Carmo","year":"2010","journal-title":"PLoS One."},{"key":"B45","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1128\/iai.72.2.988-995.2004","article-title":"Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis.","volume":"72","author":"Qi","year":"2004","journal-title":"Infect Immun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4269\/ajtmh.2007.76.669","article-title":"Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide.","volume":"76","author":"Mukbel","year":"2007","journal-title":"Am J Trop Med Hyg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.exppara.2009.09.003","article-title":"Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis.","volume":"124","author":"Fedeli","year":"2010","journal-title":"Exp Parasitol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1128\/iai.71.6.3172-3182.2003","article-title":"Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection.","volume":"71","author":"Colmenares","year":"2003","journal-title":"Infect Immun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.0141-9838.2004.00691.x","article-title":"Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis.","volume":"26","author":"Alves","year":"2004","journal-title":"Parasite Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.vetpar.2008.09.015","article-title":"Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis.","volume":"158","author":"Pereira","year":"2008","journal-title":"Vet Parasitol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1126\/science.1636092","article-title":"Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.","volume":"257","author":"Barral-Netto","year":"1992","journal-title":"Science."},{"key":"B52","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.4049\/jimmunol.161.11.6148","article-title":"The importance of TGF-\u03b2 in murine visceral leishmaniasis.","volume":"161","author":"Wilson","year":"1998","journal-title":"J Immunol."},{"key":"B53","first-page":"137","article-title":"Immunopathology of experimental cutaneous leishmaniasis.","volume":"114","author":"Andrade","year":"1984","journal-title":"Am. J. Pathol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1590\/s0074-02761992000500010","article-title":"Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine.","volume":"87","author":"Calabrese","year":"1992","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00177","article-title":"Propionibacterium acnes enhances the immunogenicity of HIVBr18. human immunodeficiency virus-1 vaccine.","volume":"9","author":"Teixeira","year":"2018","journal-title":"Front Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1590\/S0074-02761999000400020","article-title":"Atypical mucocutaneous leishmaniasis caused by Leishmania braziliensis in an acquired immunodeficiency syndrome patient: T-cell responses and remission of lesions associated with antigen immunotherapy.","volume":"94","author":"Da-Cruz","year":"1999","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/infdis\/jit378","article-title":"A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis.","volume":"208","author":"Daftarian","year":"2013","journal-title":"J Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1073\/pnas.92.8.3142","article-title":"Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam.","volume":"92","author":"Gary","year":"1995","journal-title":"Proc Natl Acad Sci USA."},{"key":"B59","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1017\/s0031182013001959","article-title":"Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB\/c mice.","volume":"141","author":"Joshi","year":"2013","journal-title":"Parasitology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","article-title":"Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial.","volume":"41","author":"Pinto","year":"2002","journal-title":"Int J Derm."},{"key":"B61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1590\/s0074-02762001000100010","article-title":"Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment.","volume":"96","author":"Toledo","year":"2001","journal-title":"Mem Inst Oswaldo Cruz."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:24:58Z","timestamp":1695860698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2020.00345"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00345","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"article-number":"345"}}